Electron transfer partners of cytochrome P450

Cytochrome P450: Structure, Mechanism, and Biochemistry: Third edition

Volumn , Issue , 2005, Pages 115-148

  Paine, Mark J I ^a   Scrutton, Nigel S ^b   Munro, Andrew W ^b   Gutierrez, Aldo ^b   Roberts, Gordon C K ^b   Roland Wolf, C ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84892304480     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/0-387-27447-2_4     Document Type: Chapter

References (221)

1. Schenkman, J. B. and I. Jansson (1999). Interactions between cytochrome P450 and cytochrome b5. Drug Metab. Rev. 31, 351-364.
2. Munro, A. W., D. G. Leys, K. J. McLean, K. R. Marshall, T. W. B. Ost, S. Daff et al. (2002). P450 BM3: The very model of a modern flavocytochrome. Trends Biochem. Sci. 27, 250-257.
3. Nakayama, N., A. Takemae, and H. Shoun (1996). Cytochrome P450foxy, a catalytically self-sufficient fatty acid hydroxylase of the fungus Fusarium oxysporum. J. Biochem. (Tokyo) 119, 435-440.
4. De Mot, R. and A. H. Parret (2002). A novel class of self-sufficient cytochrome P450 monooxygenases in prokaryotes. Trends Microbiol. 10, 502-508.
5. Kluck, R. M., E. Bossy-Wetzel, D. R. Green, and D. D. Newmeyer (1997). The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis. Science 275, 1132-1136.
6. Kluck, R. M., S. J. Martin, B. M. Hoffman, J. S. Zhou, D. R. Green, and D. D. Newmeyer (1997). Cytochrome c activation of CPP32-like proteolysis plays a critical role in a Xenopus cell-free apoptosis system. EMBOJ. 16, 4639-4649.
7. Haas, E., B. L. Horecker, and T. T. Hogness (1940). The enzymatic reduction of cytochrome c: Cytochrome c reductase. J. Biol. Chem. 136, 747-774.
8. Horecker, B. L. (1950). Triphosphopyridine nucleotide-cytochrome c reductase in liver. J. Biol. Chem. 183, 593-605.
9. Williams, C. H., Jr. and H. Kamin (1962). Microsomal triphosphopyridine nucleotide-cytochrome reductase of the liver. J. Biol. Chem. 237, 587-595.
10. Phillips, A. H. and R. G. Langdon (1962). Hepatic triphosphopyridine nucleotide cytochrome c reductase: Isolation characterisation and kinetic studies. J. Biol. Chem. 237, 2652-2660.
11. Lu, A. Y. and M. J. Coon (1968). Role of hemoprotein P-450 in fatty acid omega-hydroxylation in a soluble enzyme system from liver microsomes. J. Biol. Chem. 243, 1331-1332.
12. Lu, A. Y., K. W. Junk, and M. J. Coon (1969). Resolution of the cytochrome P-450-containing omega-hydroxylation system of liver microsomes into three components. J. Biol. Chem. 244, 3714-3721.
13. Strobel, H. W., A. Y. Lu, J. Heidema, and M. J. Coon (1970). Phosphatidylcholine requirement in the enzymatic reduction of hemoprotein P-450 and in fatty acid, hydrocarbon, and drug hydroxylation. J. Biol. Chem. 245, 4851-4854.
14. Black, S. D., J. S. French, C. H. Williams, Jr., and M. J. Coon (1979). Role of a hydrophobic polypeptide in the N-terminal region of NADPH-cytochrome P-450 reductase in complex formation with P-450LM. Biochem. Biophys. Res. Commun. 91, 1528-1535.
15. Yasukochi, Y. and B. S. Masters (1976). Some properties of a detergent-solubilized NADPH-cytochrome c (cytochrome P-450) reductase purified by biospecific affinity chromatography. J. Biol. Chem. 251, 5337-5344.
16. Iyanagi, T. and H. S. Mason (1973). Some properties of hepatic reduced nicotinamide adenine dinucleotide phosphate-cytochrome c reductase. Biochemistry 12, 2297-2308.
17. Iyanagi, T., N. Makino, and H. S. Mason (1974). Redox properties of the reduced nicotinamide adenine dinucleotide phosphate-cytochrome P-450 and reduced nicotinamide adenine dinucleotidecytochrome b5 reductases. Biochemistry 13, 1701-1710.
18. Backes, W. L. (1993). NADPH-cytochrome P450 reductase: Function. In J. B. Schenkman and H. Greim (eds) Handbook of Experimental Pharmacology, Vol. 105. Springer-Verlag, Berlin.
19. Porter, T. D. and C. B. Kasper (1985). Coding nucleotide sequence of rat NADPH-cytochrome P-450 oxidoreductase cDNA and identification of flavin-binding domains. Proc. Natl. Acad. Sci. USA 82, 973-977.
20. Katagiri, M., H. Murakami, Y. Yabusaki, T. Sugiyama, M. Okamoto, T. Yamano et al. (1986). Molecular cloning and sequence analysis of fulllength cDNA for rabbit liver NADPH-cytochrome P-450 reductase mRNA. J. Biochem. (Tokyo) 100, 945-954.
21. Yamano, S., T. Aoyama, O. W. McBride, J. P. Hardwick, H. V. Gelboin, and F. J. Gonzalez (1989). Human NADPH-P450 oxidoreductase: Complementary DNA cloning, sequence and vaccinia virus-mediated expression and localization of the CYPOR gene to chromosome 7. Mol. Pharmacol. 36, 83-88.
22. Wang, M., D. L. Roberts, R. Paschke, T. M. Shea, B. S. Masters, and J. J. Kim (1997). Three-dimensional structure of NADPH-cytochrome P450 reductase: Prototype for FMN- and FAD-containing enzymes. Proc. Natl. Acad. Sci. USA 94, 8411-8416.
23. Porter, T. D. and C. B. Kasper (1986). NADPH-cytochrome P-450 oxidoreductase: Flavin mononucleotide and flavin adenine dinucleotide domains evolved from different flavoproteins. Biochemistry 25, 1682-1687.
24. Leclerc, D., A. Wilson, R. Dumas, C. Gafuik, D. Song, D. Watkins et al. (1998). Cloning and mapping of a cDN A for methionine synthase reductase, a flavoprotein defective in patients with homocystinuria. Proc. Natl. Acad. Sci. USA 95, 3059-3064.
25. Paine, M. J., A. P. Garner, D. Powell, J. Sibbald, M. Sales, N. Pratt et al. (2000). Cloning and characterization of a novel human dual flavin reductase. J. Biol. Chem. 275, 1471-1478.
26. McMillan, K., D. S. Bredt, D. J. Hirsch, S. H. Snyder, J. E. Clark, and B. S. Masters (1992). Cloned, expressed rat cerebellar nitric oxide synthase contains stoichiometric amounts of heme, which binds carbon monoxide. Proc. Natl. Acad. Sci. USA 89, 11141-11145.
27. Narhi, L. O. and A. J. Fulco (1986). Characterization of a catalytically self-sufficient 119, 000-dalton cytochrome P-450 monooxygenase induced by barbiturates in Bacillus megaterium. J. Biol. Chem. 261, 7160-7169.
28. Ostrowski, J., M. J. Barber, D. C. Rueger, B. E. Miller, L. M. Siegel, and N. M. Kredich (1989). Characterization of the flavoprotein moieties of NADPH-sulfite reductase from Salmonella typhimurium and Escherichia coli. Physicochemical and catalytic properties, amino acid sequence deduced from DNA sequence of cysJ, and comparison with NADPH-cytochrome P-450 reductase. J. Biol. Chem. 264, 15796-15808.
29. Smith, G. C. M., D. G. Tew, and C. R. Wolf (1994). Dissection of NADPH-cytochrome P450 oxidoreductase into distinct functional domains. Proc. Natl. Acad. Sci. USA 91, 8710-8714.
30. Hodgson, A. V and H. W. Strobel (1996). Characterization of the FAD binding domain of cytochrome P450 reductase. Arch. Biochem. Biophys. 325, 99-106.
31. Sevrioukova, I., G. Truan, and J. A. Peterson (1996). The flavoprotein domain of P450BM-3: Expression, purification, and properties of the flavin adenine dinucleotide- and flavin mononucleotide-binding subdomains. Biochemistry 35, 7528-7535.
32. Munro, A. W. (1993). Purification schemes for the constituent domains of cytochrome P450 BM3 in E. coli. Biochem. Soc. Trans. 21, 316S.
33. Finn, R. D., J. Basran, O. Roitel, C. R. Wolf, A. W. Munro, M. J. Paine et al. (2003). Determination of the redox potentials and electron transfer properties of the FAD- and FMN-binding domains of the human oxidoreductase NR1. Eur. J. Biochem. 270, 1164-1175.
34. Wolthers, K. R., J. Basran, A. W. Munro, and N. S. Scrutton (2003). Molecular dissection of human methionine synthase reductase: Determination of the flavin redox potentials in full-length enzyme and isolated flavin-binding domains. Biochemistry 42, 3911-3920.
35. Benveniste, I., A. Lesot, M. P. Hasenfratz, G. Kochs, and F. Durst (1991). Multiple forms of NADPH-cytochrome P450 reductase in higher plants. Biochem. Biophys. Res. Commun. 177, 105-112.
36. Koopmann, E. and K. Hahlbrock (1997). Differentially regulated NADPHxytochrome P450 oxidoreductases in parsley. Proc. Natl. Acad. Sci. USA 94, 14954-14959.
37. Urban, P., C. Mignotte, M. Kazmaier, F. Delorme, and D. Pompon (1997). Cloning, yeast expression, and characterization of the coupling of two distantly related Arabidopsis thaliana NADPH-cytochrome P450 reductases with P450 CYP73A5. J. Biol. Chem. 272, 19176-19186.
38. Porter, T. D., T. W. Beck, and C. B. Kasper (1990). NADPH-cytochrome P-450 oxidoreductase gene organization correlates with structural domains of the protein. Biochemistry 29, 9814-9818.
39. Henderson, C. J., D. M. Otto, D. Carrie, M. A. Magnuson, A. W. McLaren, I. Rosewell et al. (2003). Inactivation of the hepatic cytochrome P450 system by conditional deletion of hepatic cytochrome P450 reductase. J. Biol. Chem. 278, 13480-13486.
40. Shen, A. L., K. A. O'Leary, and C. B. Kasper (2002). Association of multiple developmental defects and embryonic lethality with loss of microsomal NADPH-cytochrome P450 oxidoreductase. J. Biol. Chem. 277, 6536-6541.
41. Gonzalez, F. J. and C. B. Kasper (1982). Cloning of DNA complementary to rat liver NADPH-cytochrome c (P-450) oxidoreductase and cytochrome P-450b mRNAs. Evidence that phenobarbital augments transcription of specific genes. J. Biol. Chem. 257, 5962-5968.
42. Shen, A. L. and C. B. Casper (1993). Protein and gene regulation of NADPH-cytochrome P450 oxidoreductase. In J. B. Shenkman and H. Grein (eds), Handbook of Experimental Pharamacology, Vol. 105. Springer-Verlag, Berlin.
43. O'Leary, K. A., P. McQuiddy, and C. B. Kasper (1996). Transcriptional regulation of the TATA-less NADPH cytochrome P-450 oxidoreductase gene. Arch. Biochem. Biophys. 330, 271-280.
44. O'Leary, K. A., H. C. Li, P. A. Ram, P. McQuiddy, D. J. Waxman, and C. B. Kasper (1997). Thyroid regulation of NADPHxytochrome P450 oxidoreductase: Identification of a thyroid-responsive element in the 5'-flank of the oxidoreductase gene. Mol. Pharmacol. 52, 46-53.
45. Ram, P. A. and D. J. Waxman (1992). Thyroid hormone stimulation of NADPH P450 reductase expression in liver and extrahepatic tissues. Regulation by multiple mechanisms. J. Biol. Chem. 267, 3294-3301.
46. Fan, L. Q., J. Coley, R. T. Miller, R. C. Cattley, and J. C. Corton (2003). Opposing mechanisms of NADPH-cytochrome P450 oxidoreductase regulation by peroxisome proliferators. Biochem. Pharmacol. 65, 949-959.
47. Le, Y. and B. Sauer (2001). Conditional gene knockout using Cre recombinase. Mol. Biotechnol. 17, 269-275.
48. Sutter, T. R. and J. C. Loper (1989). Disruption of the Saccharomyces cerevisiae gene for NADPH-cytochrome P450 reductase causes increased sensitivity to ketoconazole. Biochem. Biophys. Res. Commun. 160, 1257-1266.
49. Venkateswarlu, K., D. C. Lamb, D. E. Kelly, N. J. Manning, and S. L. Kelly (1998). The N-terminal membrane domain of yeast NADPH-cytochrome P450 (CYP) oxidoreductase is not required for catalytic activity in sterol biosynthesis or in reconstitution of CYP activity. J. Biol. Chem. 273, 4492-4496.
50. Enoch, H. G. and P. Strittmatter (1979). Cytochrome b5 reduction by NADPH-cytochrome P-450 reductase. J. Biol. Chem. 254, 8976-8981.
51. Schacter, B. A., E. B. Nelson, H. S. Marver, and B. S. Masters (1972). Immunochemical evidence for an association of heme oxygenase with the microsomal electron transport system. J. Biol. Chem. 247, 3601-3607.
52. Chen, Z. and R. Banerjee (1998). Purification of soluble cytochrome b5 as a component of the reductive activation of porcine methionine synthase. J. Biol. Chem. 273, 26248-26255.
53. Osada, M., S. Imaoka, T. Sugimoto, T. Hiroi, and Y. Funae (2002). NADPH-cytochrome P-450 reductase in the plasma membrane modulates the activation of hypoxia-inducible factor 1. J. Biol. Chem. 277, 23367-23373.
54. Bachur, N. R., S. L. Gordon, M. V. Gee, and H. Kon (1979). NADPH cytochrome P-450 reductase activation of quinone anticancer agents to free radicals. Proc. Natl. Acad. Sci. USA 76, 954-957.
55. Keyes, S. R., P. M. Fracasso, D. C. Heimbrook, S. Rockwell, S. G. Sligar, and A. C. Sartorelli (1984). Role of NADPHxytochrome c reductase and DT-diaphorase in the biotransformation of mitomycin C1. Cancer Res. 44, 5638-5643.
56. Walton, M. I., C. R. Wolf, and P. Workman (1992). The role of cytochrome P450 and cytochrome P450 reductase in the reductive bioactivation of the novel benzotriazine di-N-oxide hypoxic cytotoxin 3-aminol, 2, 4-benzotriazine-l, 4-dioxide (SR 4233, WIN 59075) by mouse liver. Biochem. Pharmacol. 44, 251-259.
57. Vasquez-Vivar, J., P. Martasek, N. Hogg, B. S. Masters, K. A. Pritchard, Jr., and B. Kalyanaraman (1997). Endothelial nitric oxide synthase-dependent superoxide generation from adriamycin. Biochemistry 36, 11293-11297.
58. Bridges, A., L. Gruenke, Y. T. Chang, I. A. Vakser, G. Loew, and L. Waskell (1998). Identification of the binding site on cytochrome P450 2B4 for cytochrome b (5) and cytochrome P450 reductase. J. Biol. Chem. 273, 17036-17049.
59. Wang, X and P. R. Ortiz De Montellano (2003). The binding sites on human heme oxygenase-1 for cytochrome P450 reductase and biliverdin reductase. J. Biol. Chem. 6, 6.
60. Hubbard, P. A., A. X. Shen, R. Paschke, C. B. Kasper, and J. J. Kim (2001). NADPH-cytochrome P450 oxidoreductase. Structural basis for hydride and electron transfer. J. Biol. Chem. 276, 29163-29170.
61. Craig, D. H., S. K. Chapman, and S. Daff (2002). Calmodulin activates electron transfer through neuronal nitric-oxide synthase reductase domain by releasing an NADPH-dependent conformational lock. J. Biol. Chem. 277, 33987-33994.
62. Barsukov, I., S. Modi, L. Y. Lian, K. H. Sze, M. J. Paine, C. R. Wolf et al. (1997). 1H, 15N and 13C NMR resonance assignment, secondary structure and global fold of the FMN-binding domain of human cytochrome P450 reductase. J. Biomol. NMR 10, 63-75.
63. Zhao, Q., S. Modi, G. Smith, M. Paine, P. D. McDonagh, C. R. Wolf et al. (1999). Crystal structure of the FMN-binding domain of human cytochrome P450 reductase at 1. 93 A resolution. Protein Sci. 8, 298-306.
64. Ludwig, M. L., K. A. Partridge, A. L. Metzger, M. M. Dixon, M. Eren, Y. Feng et al. (1997). Control of oxidation-reduction potentials in flavodoxin from Clostridium beijerinckii: The role of conformation changes. Biochemistry 36, 1259-1280.
65. Shen, A. L., T. D. Porter, T. E. Wilson, and C. B. Kasper (1989). Structural analysis of the FMN binding domain of NADPH-cytochrome P-450 oxidoreductase by site-directed mutagenesis. J. Biol. Chem. 264, 7584-7589.
66. Paine, M. J. I., S. Ayivor, A. Munro, P. Tsan, L. Y. Lian, G. C. K. Roberts et al. (2001). Role of the conserved phenylalanine 181 of NADPH-cytochrome p450 oxidoreductase in FMN binding and catalytic activity. Biochemistry 40, 13439-13447.
67. Shen, A. L. and C. B. Kasper (2000). Differential contributions of NADPH-cytochrome P450 oxidoreductase FAD binding site residues to flavin binding and catalysis. J. Biol. Chem. 275, 41087-41091.
68. Sem, D. S. and C. B. Kasper (1992). Geometric relationship between the nicotinamide and isoalloxazine rings in NADPH-cytochrome P-450 oxidoreductase: Implications for the classification of evolutionarily and functionally related flavoproteins. Biochemistry 31, 3391-3398.
69. + binding at 2.25 A resolution. J. Mol. Biol. 263, 20-39.
70. + reductase: Protype for a structurally novel flavoenzyme family. Science 251, 60-66.
71. Gruez, A., D. Pignol, M. Zeghouf, J. Coves, M. Fontecave, J. L. Ferrer et al. (2000). Four crystal structures of the 60 kDa flavoprotein monomer of the sulfite reductase indicate a disordered flavodoxin-like module. J. Mol. Biol. 299, 199-212.
72. Dohr, O., M. J. Paine, T. Friedberg, G. C. Roberts, and C. R. Wolf (2001). Engineering of a functional human NADH-dependent cytochrome P450 system. Proc. Natl. Acad. Sci. USA 98, 81-86.
73. Gutierrez, A., O. Doehr, M. Paine, C. R. Wolf, N. S. Scrutton, and G. C. K. Roberts (2000). Trp-676 facilitates nicotinamide coenzyme exchange in the reductive half-reaction of human cytochrome P450 reductase: Properties of the soluble W676H and W676A mutant reductases. Biochemistry 39, 15990-15999.
74. Piubelli, L., A. Aliverti, A. K. Arakaki, N. Carrillo, E. A. Ceccarelli, P. A. Karplus et al. (2000). Competition between C-terminal tyrosine and nicotinamide modulates pyridine nucleotide affinity and specificity in plant ferredoxin-NADP (+) reductase. J. Biol. Chem. 275, 10472-10476.
75. + reductase revealed by protein engineering and crystallographic studies. Nat. Struct. Biol. 6, 847-853.
76. Sem, D. S. and C. B. Kasper (1993). Interaction with arginine 597 of NADPH-cytochrome P-450 oxidoreductase is a primary source of the uniform binding energy used to discriminate between NADPH and NADH. Biochemistry 32, 11548-11558.
77. Sem, D. S. and C. B. Kasper (1993). Enzyme-substrate binding interactions of NADPH-cytochrome P-450 oxidoreductase characterized with pH and alternate substrate/inhibitor studies. Biochemistry 32, 11539-11547.
78. Elmore, C. L. and T. D. Porter (2002). Modification of the nucleotide cofactor-binding site of cytochrome P-450 reductase to enhance turnover with NADH in vivo. J. Biol. Chem. 277, 48960-48964.
79. Shen, A. L. and C. B. Kasper (1996). Role of Ser457 of NADPH-cytochrome P450 oxidoreductase in catalysis and control of FAD oxidation-reduction potential. Biochemistry 35, 9451-9459.
80. Shen, A. L., D. S. Sem, and C. B. Kasper (1999). Mechanistic studies on the reductive half-reaction of NADPH-cytochrome P450 oxidoreductase. J. Biol. Chem. 274, 5391-5398.
81. Shen, A. L., D. S. Sem, and C. B. Kasper (1999). Mechanistic studies on the reductive half-reaction of NADPH-cytochrome P450 oxidoreductase. J. Biol. Chem. 274, 5391-5398.
82. Vermilion, J. L. and M. J. Coon (1978). Identification of the high and low potential flavins of liver microsomal NADPH-cytochrome P-450 reductase. J. Biol. Chem. 253, 8812-8819.
83. Vermilion, J. L. and M. J. Coon (1978). Purified liver microsomal NADPH-cytochrome P-450 reductase. Spectral characterization of oxidation-reduction states. J. Biol. Chem. 253, 2694-2704.
84. Yasukochi, Y., J. A. Peterson, and B. S. Masters (1979). NADPH-cytochrome c (P-450) reductase. Spectrophotometric and stopped flow kinetic studies on the formation of reduced flavoprotein intermediates. J. Biol. Chem. 254, 7097-7104.
85. Griffith, O. W. and D. J. Stuehr (1995). Ann. Rev. Physiol. 57, 707-736.
86. Miles, J. S., A. W. Munro, B. N. Rospendowski, W. E. Smith, J. McKnight, and A. J. Thomson (1992). Domains of the catalytically self-sufficient cytochrome P-450 BM-3. Genetic construction, overexpression, purification and spectroscopic characterization. Biochem. J. 288, 503-509.
87. Gutierrez, A., L. Y. Lian, C. R. Wolf, N. S. Scrutton, and G. C. K. Roberts (2001). Stopped-flow kinetic studies of flavin reduction in human cytochrome P450 reductase and its component domains. Biochemistry 40, 1964-1975.
88. Munro, A. W., M. A. Noble, L. Robledo, S. N. Daff, and S. K. Chapman (2001). Determination of the redox properties of human NADPH-cytochrome P450 reductase. Biochemistry 40, 1956-1963.
89. Daff, S. N., S. K. Chapman, K. L. Turner, R. A. Holt, S. Govindaraj, T. L. Poulos et al. (1997). Redox control of the catalytic cycle of flavocytochrome P450 BM3. Biochemistry 36, 13816-13823.
90. Munro, A. W., S. Daff, J. R. Coggins, J. G. Lindsay, and S. K. Chapman (1996). Probing electron transfer in flavocytochrome P-450 BM3 and its component domains. Eur. J. Biochem. 239, 403-409.
91. Noble, M. A., A. W. Munro, S. L. Rivers, L. Robledo, S. N. Daff, L. J. Yellowlees et al. (1999). Potentiometric analysis of the flavin cofactors of neuronal nitric oxide synthase. Biochemistry 38, 16413-16418.
92. Knight, K. and N. S. Scrutton (2002). Stoppedflow kinetic studies of electron transfer in the reductase domain of neuronal nitric oxide synthase: Reevaluation of the kinetic mechanism reveals new enzyme intermediates and variation with cytochrome P450 reductase. Biochem. J. 367, 19-30.
93. McLean, K. J., N. S. Scrutton, and A. W. Munro (2003). Kinetic, spectroscopic and thermodynamic characterization of the Mycobacterium tuberculosis adrenodoxin reductase homologue FprA. Biochem. J. 372, 317-327.
94. Noble, M. A., C. S. Miles, S. K. Chapman, D. A. Lysek, A. C. Mackay, G. A. Reid et al. (1999). Roles of key active site residues in flavocytochrome P450 BM3. Biochem. J. 339, 371-379.
95. Gutierrez, A., A. W. Munro, A. Grunau, C. R. Wolf, N. S. Scrutton, and G. C. K. Roberts (2003). Interflavin electron transfer in human cytochrome P450 reductase is enhanced by coenzyme binding. Eur. J. Biochem. 270, 2612-2621.
96. Bhattacharyya, A. K., J. J. Lipka, L. Waskell, and G. Tollin (1991). Laser flash photolysis studies of the reduction kinetics of NADPH: cytochrome P-450 reductase. Biochemistry 30, 759-765.
97. Gutierrez, A., M. Paine, C. R. Wolf, N. S. Scrutton, and G. C. K. Roberts (2002). Relaxation kinetics of cytochrome P450 reductase: Internal electron transfer is limited by conformational change and regulated by coenzyme binding. Biochemistry 41, 4626-4637.
98. Page, C. C., C. C. Moser, X. Chen, and P. L. Dutton (1999). Natural engineering principles of electron tunnelling in biological oxidation-reduction. Nature 402, 47-52.
99. Bayburt, T. H., J. W. Carlson, and S. G. Sligar (1998). Reconstitution and imaging of a membrane protein in a nanometer-size phospholipid bilayer. J. Struct. Biol. 123, 37-44.
100. Bayburt, T. H. and S. G. Sligar (2002). Singlemolecule height measurements on microsomal cytochrome P450 in nanometer-scale phospholipid bilayer disks. Proc. Natl. Acad. Sci. USA 99, 6725-6730.
101. Ingelman-Sundberg, M., T. Haaparanta, and J. Rydstrom (1981). Membrane charge as effector of cytochrome P-450LM2 catalyzed reactions in reconstituted liposomes. Biochemistry 20, 4100-4106.
102. Ingelman-Sundberg, M., J. Blanck, G. Smettan, and K. Ruckpaul (1983). Reduction of cyto-chrome P-450 LM2 by NADPH in reconstituted phospholipid vesicles is dependent on membrane charge. Eur. J. Biochem. 134, 157-162.
103. Coon, M. J., A. P. Autor, and H. W. Strobel (1971). Role of phospholipid in electron transfer in a reconstituted liver microsomal enzyme system containing cytochrome P-450. Chem. Biol. Interact. 3, 248-250.
104. Estabrook, R. W., A. G. Hildebrandt, J. Baron, K. J. Netter, and K. Leibman (1971). A new spectral intermediate associated with cytochrome P450 function in liver microsomes. Biochem. Biophys. Res. Commun. 42, 132-139.
105. Peterson, J. A., R. E. Ebel, D. H. O'Keeffe, T. Matsubara, and R. W. Estabrook (1976). Temperature dependence of cytochrome P-450 reduction. A model for NADPH-cytochrome P-450 reductase: cytochrome P-450 interaction. J. Biol. Chem. 251, 4010-4016.
106. Shimizu, T., T. Tateishi, M. Hatano, and Y. Fujiikuriyama (1991). Probing the role of lysines and arginines in the catalytic function of cytochrome-P450d by site-directed mutagenesis-interaction with NADPH-cytochrome-P450 reductase. J. Biol. Chem. 266, 3372-3375.
107. Shen, S. and H. W. Strobel (1993). Role of lysine and arginine residues of cytochrome P450 in the interaction between cytochrome P4502B1 and NADPH-cytochrome P450 reductase. Arch. Biochem. Biophys. 304, 257-265.
108. Bridges, A., L. Gruenke, Y. T. Chang, I. A. Vakser, G. Loew, and L. Waskell (1998). Identification of the binding site on cytochrome P450 2B4 for cytochrome 6 (5) and cytochrome P450 reductase. J. Biol. Chem. 273, 17036-17049.
109. Strobel, H. W., S. G. Nadler, and D. R. Nelson (1989). Cytochrome P-450: Cytochrome P450 reductase interactions. Drug Metab. Rev. 20, 519-533.
110. Nadler, S. G. and H. W. Strobel (1991). Identification and characterization of an NADPH-cytochrome P450 reductase derived peptide involved in binding to cytochrome P450. Arch. Biochem. Biophys. 290, 277-284.
111. Shen, S. and H. W. Strobel (1994). Probing the putative cytochrome P450- and cytochrome c-binding sites on NADPH-cytochrome P450 reductase by anti-peptide antibodies. Biochemistry 33, 8807-8812.
112. Nisimoto, Y. (1986). Localization of cytochrome cbinding domain on NADPH-cytochrome P-450 reductase. J. Biol. Chem. 261, 14232-14239.
113. Sevrioukova, I. F., H. Li, H. Zhang, J. A. Peterson, and T. L. Poulos (1999). Structure of a cytochrome P450-redox partner electron-transfer complex. Proc. Natl. Acad. Sci. USA 96, 1863-1868.
114. Voznesensky, A. I. and J. B. Schenkman (1994). Quantitative analyses of electrostatic interactions between NADPH-cytochrome P450 reductase and cytochrome P450 enzymes. J. Biol. Chem. 269, 15724-15731.
115. Voznesensky, A. I. and J. B. Schenkman (1992). The cytochrome P450 2B4-NADPH cytochrome P450 reductase electron transfer complex is not formed by charge-pairing. J. Biol. Chem. 267, 14669-14676.
116. Schenkman, J. B., A. I. Voznesensky, and I. Jansson (1994). Influence of ionic strength on the P450 monooxygenase reaction and role of cytochrome b5 in the process. Arch. Biochem. Biophys. 314, 234-241.
117. Davydov, D. R., A. A. Kariakin, N. A. Petushkova, and J. A. Peterson (2000). Association of cytochromes P450 with their reductases: Opposite sign of the electrostatic interactions in P450BM-3 as compared with the microsomal 2B4 system. Biochemistry 39, 6489-6497.
118. Munro, A. W. and J. G. Lindsay (1996). Bacterial cytochromes P-450. Mol. Microbiol. 20, 1115-1125.
119. Matson, R. S., R. S. Hare, and A. J. Fulco (1977). Characteristics of a cytochrome P-450-dependent fatty acid omega-2 hydroxylase from Bacillus megaterium. Biochim. Biophys. Acta. 487, 487-494.
120. Sueyoshi, T. and M. Negishi (2001). Phenobarbital response elements of cytochrome P450 genes and nuclear receptors. Ann. Rev. Pharmacol. Toxicol. 41, 123-143.
121. Shaw, G. C. and A. J. Fulco (1993). Inhibition by barbiturates of the binding of Bm3Rl repressor to its operator site on the barbiturate-inducible cytochrome P450BM-3 gene of Bacillus megaterium. J. Biol. Chem. 268, 2997-3004.
122. Palmer, C. N., E. Axen, V. Hughes, and C. R. Wolf (1998). The repressor protein, Bm3Rl, mediates an adaptive response to toxic fatty acids in Bacillus megaterium. J. Biol. Chem. 273, 18109-18116.
123. Fulco, A. J. (1991). P450BM-3 and other inducible bacterial P450 cytochromes: Biochemistry and regulation. Ann. Rev. Pharmacol. Toxicol. 31, 177-203.
124. Narhi, L. O. and A. J. Fulco (1987). Identification and characterization of two functional domains in cytochrome P-450BM-3, a catalytically self-sufficient monooxygenase induced by barbiturates in Bacillus megaterium. J. Biol. Chem. 262, 6683-6690.
125. Boddupalli, S. S., B. C. Pramanik, C. A. Slaughter, R. W. Estabrook, and J. A. Peterson (1992). Fatty acid monooxygenation by P450BM-3: Product identification and proposed mechanisms for the sequential hydroxylation reactions. Arch. Biochem. Biophys. 292, 20-28.
126. Peterson, J. A. and S. S. Boddupalli (1992). P450BM-3: Reduction by NADPH and sodium dithionite. Arch. Biochem. Biophys. 294, 654-661.
127. Li, H. Y., K. Darwish, and T. L. Poulos (1991). Characterization of recombinant Bacillus megaterium cytochrome P-450 BM-3 and its two functional domains. J. Biol. Chem. 266, 11909-11914.
128. Govindaraj, S. and T. L. Poulos (1997). The domain architecture of cytochrome P450BM-3. J. Biol. Chem. 272, 7915-7921.
129. Noble, M. A., C. S. Miles, S. K. Chapman, D. A. Lysek, A. C. MacKay, G. A. Reid et al. (1999). Roles of key active-site residues in flavocytochrome P450 BM3. Biochem. J. 339, 371-379.
130. Shirane, N., Z. Sui, J. A. Peterson, and P. R. Ortiz De Montellano (1993). Cytochrome P450BM-3 (CYP102): Regiospecificity of oxidation of omegaunsaturated fatty acids and mechanism-based inactivation. Biochemistry 32, 13732-13741.
131. Ost, T. W., C. S. Miles, A. W. Munro, J. Murdoch, G. A. Reid, and S. K. Chapman (2001). Phenylalanine 393 exerts thermodynamic control over the heme of flavocytochrome P450 BM3. Biochemistry 40, 13421-13429.
132. Murataliev, M. B. and R. Feyereisen (2000). Functional interactions in cytochrome P450BM3. Evidence that NADP (H) binding controls redox potentials of the flavin cofactors. Biochemistry 39, 12699-12707.
133. Murataliev, M. B. and R. Feyereisen (1999). Mechanism of cytochrome P450 reductase from the house fly: Evidence for an FMN semiquinone as electron donor. FEBS Lett. 453, 201-204.
134. Murataliev, M. B. and R. Feyereisen (2000). Interaction of NADP (H) with oxidized and reduced P450 reductase during catalysis. Studies with nucleotide analogues. Biochemistry 39, 5066-5074.
135. Munro, A. W., K. Malarkey, J. McKnight, A. J. Thomson, S. M. Kelly, N. C. Price et al. (1994). The role of tryptophan 97 of cytochrome P450 BM3 from Bacillus megaterium in catalytic function. Evidence against the 'covalent switching' hypothesis of P-450 electron transfer. Biochem. J. 303, 423-428.
136. Murakami, H., Y. Yabusaki, T. Sakaki, M. Shibata, and H. Ohkawa (1987). A genetically engineered P450 monooxygenase: Construction of the functional fused enzyme between rat cytochrome P450c and NADPH-cytochrome P450 reductase. DNA 6, 189-197.
137. Fisher, C. W., M. S. Shet, D. L. Caudle, C. A. Martin-Wixtrom, and R. W. Estabrook (1992). High-level expression in Escherichia coli of enzymatically active fusion proteins containing the domains of mammalian cytochromes P450 and NADPH-P450 reductase flavoprotein. Proc. Natl. Acad. Sci. USA 89, 10817-10821.
138. Shet, M. S., C. W. Fisher, P. L. Holmans, and R. W. Estabrook (1993). Human cytochrome P450 3A4: Enzymatic properties of a purified recombinant fusion protein containing NADPH-P450 reductase. Proc. Natl. Acad. Sci. USA 90, 11748-11752.
139. Chun, Y. J., T. Shimada, and F. P. Guengerich (1996). Construction of a human cytochrome P450 1A1: Rat NADPH-cytochrome P450 reductase fusion protein cDNA and expression in Escherichia coli, purification, and catalytic properties of the enzyme in bacterial cells and after purification. Arch. Biochem. Biophys. 330, 48-58.
140. Shet, M., C. W. Fisher, P. L. Holmans, and R. W. Estabrook (1996). The omega-hydroxlyation of lauric acid: Oxidation of 12-hydroxylauric acid to dodecanedioic acid by a purified recombinant fusion protein containing P450 4A1 and NADPH-P450 reductase. Arch. Biochem. Biophys. 330, 199-208.
141. Helvig, C. and J. H. Capdevila (2000). Biochemical characterization of rat P450 2C11 fused to rat or bacterial NADPH-P450 reductase domains. Biochemistry 39, 5196-5205.
142. Sakaki, T., S. Kominami, S. Takemori, H. Ohkawa, M. Akiyoshi-Shibata, and Y. Yabusaki (1994). Kinetic studies on a genetically engineered fused enzyme between rat cytochrome P4501A1 and yeast NADPH-P450 reductase. Biochemistry 33, 4933-4939.
143. Hayashi, K., T. Sakaki, S. Kominami, K. Inouye, and Y. Yabusaki (2000). Coexpression of genetically engineered fused enzyme between yeast NADPH-P450 reductase and human cytochrome P450 3A4 and human cytochrome b5 in yeast. Arch. Biochem. Biophys. 381, 164-170.
144. Deeni, Y. Y, M. J. Paine, A. D. Ayrton, S. E. Clarke, R. Chenery, and C. R. Wolf (2001). Expression, purification, and biochemical characterization of a human cytochrome P450 CYP2D6-NADPH cytochrome P450 reductase fusion protein. Arch. Biochem. Biophys. 396, 16-24.
145. Sanborn, R. C. and C. M. William (1950). The cytochrome system in the Cecropia silkworm, with special reference to the properties of a new component. J. Gen. Physiol. 33, 579-588.
146. Porter, T. D. (2002). The roles of cytochrome b5 in cytochrome P450 reactions. J. Biochem. Mol. Toxicol. 16, 311-316.
147. Vergeres, G. and L. Waskell (1995). Cytochrome b5, its functions, structure and membrane topology. Biochimie 11, 604-620.
148. Hildebrandt, A. and R. W. Estabrook (1971). Evidence for the participation of cytochrome b5 in hepatic microsomal mixed-function oxidation reactions. Arch. Biochem. Biophys. 143, 66-79.
149. Correia, M. A. and G. J. Mannering (1973). Reduced diphosphopyridine nucleotide synergism of the reduced triphosphopyridine nucleotidedependent mixed-function oxidase system of hepatic microsomes. II. Role of the type I drug-binding site of cytochrome P-450. Mol. Pharmacol. 9, 470-485.
150. Yamazaki, H., M. Nakamura, T. Komatsu, K. Ohyama, N. Hatanaka, S. Asahi et al. (2002). Roles of NADPH-P450 reductase and apo- and holo-cytochrome b5 on xenobiotic oxidations catalyzed by 12 recombinant human cytochrome P450s expressed in membranes of Escherichia coli. Protein Expr. Purif. 24, 329-337.
151. Voice, M. W., Y. Zhang, C. R. Wolf, B. Burchell, and T. Friedberg (1999). Effects of human cytochrome b5 on CYP3A4 activity and stability in vivo. Arch. Biochem. Biophys. 366, 116-124.
152. Hlavica, P. and D. F. Lewis (2001). Allosteric phenomena in cytochrome P450-catalyzed monooxygenations. Eur. J. BioChem. 268, 4817-4832.
153. Mitoma, J. and A. Ito (1992). The carboxy-terminal 10 amino acid residues of cytochrome b5 are necessary for its targeting to the endoplasmic reticulum. EMBOJ. 11, 4197-4203.
154. Keyes, S. R. and D. L. Cinti (1980). Biochemical properties of cytochrome b5-dependent microsomal fatty acid elongation and identification of products. J. Biol. Chem. 255, 11357-11364.
155. Oshino, N., Y. Imai, and R. Sato (1971). A function of cytochrome b5 in fatty acid desaturation by rat liver microsomes. J. Biochem. (Tokyo) 69, 155-167.
156. Reddy, V. V., D. Kupfer, and E. Caspi (1977). Mechanism of C-5 double bond introduction in the biosynthesis of cholesterol by rat liver microsomes. J. Biol. Chem. 252, 2797-2801.
157. Hegesh, E., J. Hegesh, and A. Kaftory (1986). Congenital methemoglobinemia with a deficiency of cytochrome b5. N. Engl. J. Med. 314,
158. Manabe, J., R. Arya, H. Sumimoto, T. Yubisui, A. J. Bellingham, D. M. Layton et al. (1996). Two novel mutations in the reduced nicotinamide adenine dinucleotide (NADH)-cytochrome b5 reductase gene of a patient with generalized type, hereditary methemoglobinemia. Blood 88, 3208-3215.
159. Tamburini, P. P., S. MacFarquhar, and J. B. Schenkman (1986). Evidence of binary complex formations between cytochrome P-450, cytochrome b5, and NADPH-cytochrome P-450 reductase of hepatic microsomes. Biochem. Biophys. Res. Commun. 134, 519-526.
160. Stayton, P. S. and S. G. Sligar (1990). The cytochrome P-450cam binding surface as defined by site-directed mutagenesis and electrostatic modeling. Biochemistry 29, 7381-7386.
161. Omata, Y., H. Sakamoto, R. C. Robinson, M. R. Pincus, and F. K. Friedman (1994). Interaction between cytochrome P450 2B1 and cytochrome b5: Inhibition by synthetic peptides indicates a role for P450 residues Lys-122 and Arg-125. Biochem. Biophys. Res. Commun. 201, 1090-1095.
162. Omata, Y., R. C. Robinson, H. V. Gelboin, M. R. Pincus, and F. K. Friedman (1994). Specificity of the cytochrome P-450 interaction with cytochrome b5. FEBS Lett. 346, 241-245.
163. Guengerich, F. P. (1983). Oxidation-reduction properties of rat liver cytochromes P-450 and NADPH-cytochrome p-450 reductase related to catalysis in reconstituted systems. Biochemistry 22, 2811-2820.
164. Yamazaki, H., W. W. Johnson, Y.-F. Ueng, T. Shimada, and F. P. Guengerich (1996). Lack of electron transfer from cytochrome b5 in stimulation of catalytic activities of cytochrome P450 3A4. Characterization of a reconstituted cytochrome P450 3A4/NADPH-cytochrome P450 reductase system and studies with apo-cytochrome b5. J. Biol. Chem. 271, 27438-27444.
165. Yamazaki, H., T. Shimada, M. V. Martin, and F. P. Guengerich (2001). Stimulation of cytochrome P450 reactions by apocytochrome b5. Evidence against transfer of heme from cytochrome P450 3A4 to apo-cytochrome b5 or heme oxygenase. J. Biol. Chem. 276, 30885-30891.
166. Yamazaki, H., M. Nakano, Y. Imai, Y. F. Ueng, F. P. Guengerich, and T. Shimada (1996). Roles of cytochrome b5 in the oxidation of testosterone and nifedipine by recombinant cytochrome P450 3A4 and by human liver microsomes. Arch. Biochem. Biophys. 325, 174-182.
167. Bell, L. C. and F. P. Guengerich (1997). Oxidation kinetics of ethanol by human cytochrome P450 2E1. Rate-limiting product release accounts for effects of isotopic hydrogen substitution and cytochrome b5 on steady-state kinetics. J. Biol. Chem. 272, 29643-29651.
168. Schenkman, J. B., A. I. Voznesensky, and I. Jansson (1994). Influence of ionic strength on the P450 monooxygenase reaction and role of cytochrome b5 in the process. Arch. Biochem. Biophys. 314, 234-241.
169. Perret, A. and D. Pompon (1998). Electron shuttle between membrane-bound cytochrome P450 3A4 and b5 rules uncoupling mechanisms. Biochemistry 37, 11412-11424.
170. Gruenke, L. D., K. Konopka, M. Cadieu, and L. Waskell (1995). The stoichiometry of the cytochrome P-450-catalyzed metabolism of methoxyflurane and benzphetamine in the presence and absence of cytochrome b5. J. Biol. Chem. 270, 24707-24718.
171. Wang, M. H., C. J. Patten, G. Y. Yang, S. R. Paranawithana, Y. Tan, and C. S. Yang (1996). Expression and coupling of human cytochrome P450 2E1 and NADPH-cytochrome P450 oxidoreductase in dual expression and co-infection systems with baculovirus in insect cells. Arch. Biochem. Biophys. 334, 380-388.
172. Cooper, M. T. and T. D. Porter (2001). Cytochrome b (5) coexpression increases the CYP2E1-dependent mutagenicity of dialkylnitrosamines in methyltransferase-deficient strains of Salmonella typhimurium. Mutat. Res. 484, 61-68.
173. Jansson, I. and J. B. Schenkman (1987). Influence of cytochrome b5 on the stoichiometry of the different oxidative reactions catalyzed by liver microsomal cytochrome P-450. Drug Metab. Dispos. 15, 344-348.
174. Grinberg, A. V., F. Hannemann, B. Schiffler, J. Muller, U. Heinemann, and R. Bernhardt (2000). Adrenodoxin: Structure, stability, and electron transfer properties. Proteins 40, 590-612.
175. Poulos, T. L., B. C. Finzel, and A. J. Howard (1987). High-resolution crystal structure of cytochrome P450cam. J. Mol Biol. 195, 687-700.
176. Mathews, F. S., A. G. Mauk, and G. R. Moore (2000). In C. Kleanthous (ed.), Protein-Protein Recognition. Oxford University Press, Oxford, pp. 60-101.
177. Shimada, H., S. Nagano, H. Hori, and Y. Ishimura (2001). Putidaredoxin-cytochrome P450cam interaction. J. Inorg. Biochem. 83, 255-260.
178. Trower, M. K., R. Lenstra, C. Omer, S. E. Buchholz, and F. S. Sariaslani (1992). Cloning, nucleotide sequence determination and expression of the genes encoding cytochrome P-450soy (soyC) and ferredoxinsoy (soyB) from Streptomyces griseus. Mol. Microbiol. 6, 2125-2134.
179. Green, A. J., A. W. Munro, M. R. Cheesman, G. A. Reid, C. Von Wachenfeldt, and S. K. Chapman (2003). Expression, purification and characterisation of a Bacillus subtilis ferredoxin: A potential electron transfer donor to cytochrome P450 Biol. J. Inorg. Biochem. 93, 92-99.
180. Matocha, M. F. and M. R. Waterman (1984). Discriminatory processing of the precursor forms of cytochrome P-450scc and adrenodoxin by adrenocortical and heart mitochondria. J. Biol. Chem. 259, 8672-8678.
181. Matsubara, H. and K. Saeki (1992). Structural and functional diversity of ferredoxins and related proteins. Adv. Inorg. Chem. 38, 223-280.
182. Sevrioukova, I. F. and T. L. Poulos (2002). Putidaredoxin reductase, a new function for an old protein. J. Biol. Chem. 277, 25831-25839.
183. Omura, T., E. Sanders, R. W. Estabrook, D. Y. Cooper, and O. Rosenthal (1966). Isolation from adrenal cortex of a nonheme iron protein and a flavoprotein functional as a reduced triphosphopyridine nucleotide-cytochrome P-450 reductase. Arch. Biochem. Biophys. 117, 660-673.
184. Hanukoglu, I., C. T. Privalle, and C. R. Jefcoate (1981). Mechanisms of ionic activation of adrenal mitochondrial cytochromes P-450scc and P-45011 beta. J. Biol. Chem. 256, 4329-4335.
185. Ziegler, G. A., C. Vonrhein, I. Hanukoglu, and G. E. Schulz (1999). The structure of adrenodoxin reductase of mitochondrial P450 systems: Electron transfer for steroid biosynthesis. J. Mol. Biol. 289, 981-990.
186. + revealed by the atomic resolution structure of FprA, a Mycobacterium tuberculosis oxidoreductase, Biochemistry 41, 8807-8818.
187. Hanukoglu, I. (1992). Steroidogenic enzymes: Structure, function, and role in regulation of steroid hormone biosynthesis. J. Steroid. Biochem. Mol. Biol. 43, 779-804.
188. Pochapsky, T. C., N. U. Jain, M. Kuti, T. A. Lyons, and J. Heymont (1999). A refined model for the solution structure of oxidized putidaredoxin. Biochemistry 38, 4681-4690.
189. Fukuyama, K., T. Okada, Y. Kakuta, and Y. Takahashi (2002). Atomic resolution structures of oxidized [4Fe-4S] ferredoxin from Bacillus thermoproteolyticus in two crystal forms: Systematic distortion of [4Fe-4S] cluster in the protein. J. Mol. Biol. 315, 1155-1166.
190. Holden, M., M. Mayhew, D. Bunk, A. Roitberg, and V. Vilker (1997). Probing the interactions of putidaredoxin with redox partners in camphor P450 5-monooxygenase by mutagenesis of surface residues. J. Biol. Chem. 272, 21720-21725.
191. Unno, M., J. F. Christian, T. Sjodin, D. E. Benson, I. D. Macdonald, S. G. Sligar et al. (2002). Complex formation of cytochrome P450cam with Putidaredoxin. Evidence for protein-specific interactions involving the proximal thiolate ligand. J. Biol. Chem. 277, 2547-2553.
192. Roitberg, A., H. M. Holden, M. P. Mayhew, I. V. Kurnikov, D. N. Beraten, and V. L. Vilker (1998). Binding and electron transfer between putidaredoxin and cytochrome P450cam. J. Am. Chem. Soc. 120, 8927-8932.
193. Davies, M. D. and S. G. Sligar (1992). Genetic variants in the putidaredoxin-cytochrome P-450cam electron-transfer complex: Identification of the residue responsible for redox-state-dependent conformers. Biochemistry 31, 11383-11389.
194. Stayton, P. S. and S. G. Sligar (1990). The cytochrome P-450cam binding surface as defined by site-directed mutagenesis and electrostatic modeling. Biochemistry 29, 7381-7386.
195. Aoki, M., K. Ishimori, H. Fukada, K. Takahashi, and I. Morishima (1998). Isothermal titration calorimetric studies on the associations of putidaredoxin to NADH-putidaredoxin reductase and P450cam. Biochim. Biophys. Acta. 1384, 180-188.
196. Mueller, E. J., P. J. Loida, and S. G. Sligar (1995). In P. R. Ortiz de Montellano (ed.), Cytochrome P450; Structure, Mechanism and Biochemistry (2nd edn.). Plenum Press, New York, pp. 83-124.
197. Hintz, M. J. and J. A. Peterson (1981). The kinetics of reduction of cytochrome P-450cam by reduced putidaredoxin. J. Biol. Chem. 256, 6721-6728.
198. Roome, P. W., J. C. Philley, and J. A. Peterson (1983). Purification and properties of putidaredoxin reductase. J. Biol. Chem. 49, 10592-10600.
199. Sevrioukova, I. F., J. T. Hazzard, G. Tollin, and T. L. Poulos (2001). Laser flash induced electron transfer in P450cam monooxygenase putidaredoxin reductase-putidredoxin interaction. Biochemistry 49, 10592-10600.
200. Pochapsky, S. S., T. C. Pochapsky, and J. W. Wei (2003). A model for effector activity in a highly specific biological electron transfer complex: The cytochrome P450 (cam)-putidaredoxin couple. Biochemistry 42, 5649-5656.
201. Tosha, T., S. Yoshioka, S. Takahashi, K. Ishimori, H. Shimada, and I. Morishima (2003). NMR study on the structural changes of cytochrome P450cam upon the complex formation with putidaredoxin: Functional significance of the putidaredoxininduced structural changes. J. Biol. Chem. 2, 2.
202. Brewer, C. B. and J. A. Peterson (1988) Single turnover kinetics of the reaction between oxycytochrome P450cam and reduced putidaredoxin. J. Biol. Chem. 263, 791-798.
203. Muller, A., J. J. Muller, Y. A. Muller, H. Uhlmann, R. Bernhardt, and U. Heinemann (1998). New aspects of electron transfer revealed by the crystal structure of a truncated bovine adrenodoxin, Adx (4-108). Structure 6, 269-280.
204. Pikuleva, I. A., K. Tesh, M. R. Waterman, and Y. Kim (2000). The tertiary structure of full-length bovine adrenodoxin suggests functional dimers. Arch. Biochem. Biophys. 373, 44-55.
205. Beilke, D., R. Weiss, F. Lohr, P. Pristovsek, F. Hannemann, R. Bernhardt et al. (2002). A new electron transport mechanism in mitochondrial steroid hydroxylase systems based on structural changes upon the reduction of adrenodoxin. Biochemistry 41, 7969-7978.
206. Vickery, L. E. (1997). Molecular recognition and electron transfer in mitochondrial steroid hydroxylase systems. Steroids 62, 124-127.
207. Zollner, A., F. Hannemann, M. Lisurek, and R. Bernhardt (2002). Deletions in the loop surrounding the iron-sulfur cluster of adrenodoxin severely affect the interactions with its native redox partners adrenodoxin reductase and cytochrome P450 (scc) (CYP11A1). J. Inorg. Biochem. 91, 644-654.
208. Uhlmann, H., V. Beckert, D. Schwarz, and R. Bernhardt (1992). Expression of bovine adrenodoxin in E. coli and site-directed mutagenesis of/2 Fe-2S/cluster ligands. Biochem. Biophys. Res. Commun. 188, 1131-1138.
209. Hara, T., C. Koba, M. Takeshima, and Y. Sagara (2000). Evidence for the cluster model of mitochondrial steroid hydroxylase system derived from dissociation constants of the complex between adrenodoxin reductase and adrenodoxin. Biochem. Biophys. Res. Commun. 276, 210-215.
210. Lambeth, J. D., D. W. Seybert, J. R. Lancaster, Jr., J. C. Salerno, and H. Kamin (1982). Steroidogenic electron transport in adrenal cortex mitochondria. Mol. Cell Biochem. 45, 13-31.
211. Muller, J. J., A. Lapko, K. Ruckpaul, and U. Heinemann (2003). Modeling of electrostatic recognition processes in the mammalian mitochondrial steroid hydroxylase system. Biophys. Chem. 100, 281-292.
212. Muller, J. J., A. Lapko, G. Bourenkov, K. Ruckpaul, and U. Heinemann (2001). Adrenodoxin reductase-adrenodoxin complex structure suggests electron transfer path in steroid biosynthesis. J. Biol. Chem. 276, 2786-2789.
213. Aoki, M., K. Ishimori, and I. Morishima (1998). Roles of negatively charged surface residues of putidaredoxin in interactions with redox partners in p450cam monooxygenase system. Biochim. Biophys. Acta. 1386, 157-167.
214. Sibbesen, O., J. J. De Voss, and P. R. Ortiz De Montellano (1996). Putidaredoxin reductaseputidaredoxin-cytochrome P450cam triple fusion protein. Construction of a self-sufficient Escherichia coli catalytic system. J. Biol. Chem. 271, 22462-22469.
215. Song, W. C., C. D. Funk, and A. R. Brash (1993). Molecular cloning of an allene oxide synthase: A cytochrome P450 specialized for the metabolism of fatty acid hydroperoxides. Proc. Natl. Acad. Sci. USA 90, 8519-8523.
216. Lee, D. S., A. Yamada, H. Sugimoto, I. Matsunaga, H. Ogura, K. Ichihara et al. (2003). Substrate recognition and molecular mechanism of fatty acid hydroxylation by cytochrome P450 from Bacillus subtilis. Crystallographic, spectroscopic, and mutational studies. J. Biol. Chem. 278, 9761-9767.
217. Green, A. J., A. W. Munro, M. R. Cheesman, G. A. Reid, C. Von Wachenfeldt, and S. K. Chapman (2003). Expression, purification and characterisation of a Bacillus subtilis ferredoxin: A potential electron transfer donor to cytochrome P450 Biol. J. Inorg. Biochem. 93, 92-99.
218. Hawkes, D. B., G. W. Adams, A. L. Burlingame, P. R. Ortiz De Montellano, and J. J. De Voss (2002). Cytochrome P450 (cin) (CYP176A), isolation, expression, and characterization. J. Biol. Chem. 277, 27725-27732.
219. + oxidoreductase and flavodoxin; key components of electron transfer in Escherichia coli. Eur. J. Biochem. 257, 577-585.
220. Jackson, C. J., D. C. Lamb, T. H. Marczylo, A. G. Warrilow, N. J. Manning, D. J. Lowe et al. (2002). A novel sterol 14alpha-demethylase/ferredoxin fusion protein (MCCYP51FX) from Methylococcus capsulatus represents a new class of the cytochrome P450 superfamily. J. Biol. Chem. 277, 46959-46965.
221. Roberts, G. A., G. Grogan, A. Greter, S. L. Flitsch, and N. J. Turner (2002). Identification of a new class of cytochrome P450 from a Rhodococcus sp. J. Bacteriol. 184, 3898-3908.